Scopia Capital Management 13F holdings, Q3 2011
Holdings as of September 30, 2011 · filings on SEC EDGAR · latest filing →
Scopia Capital Management disclosed 14 US equity positions worth $373.5m in its Q3 2011 13F filing. The largest position was S9Q at 39.0% of the reported book, followed by PHH CORP and XEROX CORP. Against the Q2 2011 filing, it opened 4 new positions, added to 3 and reduced 4 among the top 14 holdings.
What did Scopia Capital Management own in Q3 2011? Top 14 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2011 |
|---|---|---|---|---|---|---|---|
| 1 | S9Q SPIRIT AEROSYSTEMS HLDGS INC | 39.0% | $145.8m | 9,143,216 | 68% | added | |
| 2 | PHH CORP | 23.6% | $88.3m | 5,489,300 | 0% | held | |
| 3 | XEROX CORP | 15.6% | $58.1m | 8,340,228 | 3% | added | |
| 4 | PLAINS EXPL& PRODTN CO | 6.9% | $25.8m | 1,137,099 | -31% | reduced | |
| 5 | FCX FREEPORT-MCMORAN COPPER & GO | Basic Materials | 3.4% | $12.6m | 413,900 | -56% | reduced |
| 6 | OMNIVISION TECHNOLOGIES INC | 2.5% | $9.5m | 676,409 | 218% | added | |
| 7 | CLNE CLEAN ENERGY FUELS CORP | Energy | 2.3% | $8.4m | 757,890 | 0% | held |
| 8 | LUFKIN INDS INC | 2.1% | $7.8m | 146,236 | – | new | |
| 9 | ALLOS THERAPEUTICS INC | 1.6% | $6.0m | 3,265,409 | – | new | |
| 10 | SEATTLE GENETICS INC | 1.6% | $5.9m | 307,858 | – | new | |
| 11 | SNYDERS-LANCE INC | 0.7% | $2.6m | 124,689 | -75% | reduced | |
| 12 | AMERICAN SUPERCONDUCTOR CORP | 0.6% | $2.2m | 572,651 | 0% | held | |
| 13 | WMB WILLIAMS COS INC DEL | Energy | 0.1% | $359.0k | 14,760 | -99% | reduced |
| 14 | QLT INC | 0.0% | $88.0k | 12,100 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.